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ABSTRAK
Kajian ini dijalankan untuk menentukan keberkesanan ekstrak berakua Plantago major untuk rnerawat diabetes
mellitus dan meningkatkan kesuburan lelaki. Gin-cin hipoglisemia ekstrak daun P. major ditentukan dengan
memberikan empat dos rawatan secara oral (l00, 200, 400 dan 600 mg/kg berat badan). Salin dan
glibenklamida disediakan sebagai kawalan. Ujian Toleransi Glukosa dilakukan pada masa -10, 0, 5, 15, 30,
60, 120 dan 180 minit lalu kepekatan glukosa plasma darah ditentukan dengan ujian oksidase glukosa.
Keputusan kajian menunjukkan bahawa dos rawatan 600 mg/kg berupaya merendahkan aras glukosa darah
tikus diabetik. Walau bagaimanapun, kesan ekstrak kurang ketara berbanding dengan glibenklamida. Dalam
kajian kesuburan, ekstrak berakua biji P. major pada dos rawatan berbeza (30, 60, 100 dan 200 mg/kg berat
badan) diberikan secara oral kepada tikus. Kesan setiap dos ke atas kepekatan sperma vas deferens selepas 120
han ditentukan. Keputusan kajian menunjukkan bahawa dos-dos 60, 100 dan 200 mg/kg meningkatkan
kepekatan sperma. Walau bagaimanapun, peningkatan aras testosteron adalah tidak ketara pada hari ke-8 dan
ke-14 untuk dos 60 dan 200 mg/kg. Faktor lain yang mungkin mempengaruhi keputusan ini ialah ciri
antiestrogen bijinya yang mempunyai kesan spermatigenik. Keputusan kajian ini menunjukkan bahawa ekstrak
berakua P. major mungkin mengandungi bahan kimia untuk merawat diabetes mellitus dan masalah
ketidaksuburan lelaki.
ABSTRACT
Plantago major extract has been traditionally used for treating diabetes and to increase male fertility. This study
was conducted to verify its efficacy. The hypoglycaemic property ofP. major aqueous leaf extract was determined
1Yy oral administration of four treatment doses (l00, 200, 400 and 600 mg/kg body weight). Saline and
glibenclamide were used as controls. Glucose Tolerance Test was done at -10, 0, 5, 15, 30, 60, 90, 120 and
180 minutes and the plasma glucose concentration was determined 1Yy the glucose oxidase assay. The study showed
that only the 600 mg/kg dose had a significant effect in reducing blood glucose level in diabetic rats. However,
the effect of the aqueous extracts was less pronounced compared to glibenclamide. In the fertility study, an aqueous
extract from P. major seeds was given orally to rats at 30, 60, 100 and 200 mg/kg body weight respectively. The
effect of each dose on vas deferens sperm concentrations after 20 days of treatment was determined. Analysis of
the data showed significant increases in sperm concentrations in the 60, 100 and 200 mg/kg body weight groups.
However, the trend in increased testosterone levels from day 8 to 14 in the 60 and 200 mg/kg groups was
insignificant, suggestive ofotherfactors, possibly antiestrogens in the seed extract contributing to the spermatogenic
effect. The studies suggest that aqueous extract from P. major could contain chemicals for treating diabetes
mellitus and male infertility problems.
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INTRODUCTION
In Malaysia, Plantago major ('Ekor Anjing' in
Malay) has been used by the Chinese and Malays
as a diuretic, tonic (Hyatt 1978) and cough
mixture (Muhammad and Mustafa 1994). It is
also a folk remedy for the blacks in South Mrica
(Veale et al. 1992), Spanish and Mexican (Conway
and Slocumb 1979) and the natives in Brazil
(Franca et al. 1996). Recent research on P. major
has touched on anti-cancer (Lithander 1992),
anti-inflammation (Nunez-Guillen et al. 1997),
anti-oedema (Than et al. 1996) and anti-ulcero-
genic properties (Yesilada et al. 1993) to name
but a few. Other uses of the plant for treatment
of various diseases are summarized in Table 1.
TABLE 1
Other medicinal uses of P. major
Usage References
1 Treatment for panaritium Dharma 1987
2 To induce abortion Conway and
Slocumb 1979
3 Promote blood coagulation Hornok 1992
4 Treatment against Franca et al.
Leishmanial ulcers on skin 1996
5 Remedy for gall and Riawan and
renal stones Sangat-
Roemantyo
1992
6 Chronic bronchitis Matev et al.
1982
7 Anti-parasi tic properties Ponce et al.
against G.duodenalis 1994
10 Stimulate mucus and Vymyatnina
proteolytic activity of 1997
gastric juice
11 Anti-bacterial activity Ravn and
Brimer 1988
12 Anti-nematodal Insunza and
Valenzuela
1995
13 Treatment against Amanita Perez-Silva
sp. poisoning and Herrera
1992
14 Treatment of mastitis Deryabin 1991
15 Promote wound healing Salas-Auvert
et al. 1985
The prevalence of diabetes mellitus in the
general population is on the upswing while over
the past 40 years, male fertility has declined
alarmingly. In traditional Malay medicine, Plan-
tago major is used for treating diabetes mellitus
(Muhammad and Mustafa 1994). Hypoglycae-
mic studies had been done locally on plant
extracts such as Akar Seruntun (Tinospora crispa)
(Noor and Ashcroft 1998), Petai Papan (Parkia
speciosa) (Fathaiya et al. 1995) and fenugreek
seeds (Trigonella foenum-graecum) (Mariam et al.
1995). Modern treatments such as with oral
hypoglycaemic like glibenclamide and
troglitazone unfortunately could cause hepatic
dysfunction to the patient, which in several in-
stances has been fatal (Watkin and Whitcomb
1998). Therefore Ajgoankar (1979) had sug-
gested alternative treatment of diabetes mellitus,
using oral administration of plant extracts based
on traditional medicine.
Meanwhile, in traditional Chinese medicine,
P. major is said to be able to increase sperm and
fertility (Hyatt 1978). Historically, a number of
plants have been used as sex hormones in native
medicine (Farnsworth et al. 1975). Plants that
have been used in fertility enhancement include
Panax schinseng, Trigonella foenum-graecum (Lucas
1978) and Epimedium brevicornum Maxim. (Lu
1994).
The objective of this study is to verify the
hypoglycaemic and fertility enhancing proper-
ties of Plantago major extract.
MATERIALS AND METHODS
Preparation of Extracts
Plantago major seeds were obtained from Sibu,
Sarawak and were planted at UPM Biology De-
partment's nursery for three months. The leaves
were dried and boiled in 0.5 liter of water for 5
minutes. In the male fertility study, the aqueous
seed extract of Plantago major was used. The
aqueous extract was prepared using the Soxhlet
extraction apparatus (Soxhlet Electrothermal,
England). Both extracts were then concentrated
and later freeze dried at -70°C to obtain the
powder form.
Experimental Procedure
The experimental animals used were white al-
bino rats (250-350g) of the Sprague Dawley strain.
They were given food pellets (Gold Coin (M)
Bhd. Pelabuhan Kelang, Selangor) and drinking
water ad libitum.
Hypoglycaemic Study
The rats were intravenously i~ected with 40
mg/kg body weight of alloxan monohydrate to
induce diabetes. Only rats with blood glucose
concentration of 250 - 400 mg/dl were selected
for the experiment.
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The diabetic rats were divided into 6 groups
(5 rats each). The fIrst two groups were treated
with saline 0.95% (5mljkg) and glibenclamide
(lOmg/kg) as controls. The other four groups
were treated with water extracts of various doses
(l00, 200, 400 and 600 mg/kg). Saline,
glibenclamide and the water extracts were ad-
ministered through oral catheter. The rats were
anaesthetized with Zoletil 50 and blood samples
were obtained from the tip of the tail (Noor and
Ashcroft 1989).
For the Oral Glucose Tolerance Test, the
rats were fasted overnight before the test. The
fIrst sampling was obtained at time -10 minute
and another sampling at time 0 minute, fol-
lowed by treatment administration. After 15
minutes, a glucose load of 1.5g/kg rat body
weight was orally administered. Consecutive
blood samples were taken at 5, 15, 30, 60, 90,
120 and 180 minutes after the oral glucose load.
The blood glucose concentrations in the sam-
ples (mg% or mg/100ml) were analyzed by
Glucose Oxidase method (GOD-Perid Method,
Boehringer Mannheim).
Areas under the blood glucose concentra-
tion curves (AUC) were calculated by trapezoidal
integration method (Campbell and Madden,
1990) whereby
Area under curve (AUC)
n-l
= ~ [(:Y; + :Y;+l) / 2][t;+1 - tJ
In which
n is the number of replicates
(~ + ~ + 1) /2 is the height of the rectangle
(estimated as the midpoint
between ~ and ~ + 1) in mg%
t; + 1 - t; is the width of the rectangle in
minutes
Male Fertility Study
The seed extract was given orally to four groups
of rats with doses of 30, 60, 100, and 200 mg/kg
body weight. 0.95% saline solution was used for
control purpose. Treatment was given every day
immediately after blood sampling using an oral
catheter that was connected to a syringe. Blood
samples were taken from the tail tip at days 0, 8,
14 and 20. The blood and later the serum were
both centrifuged at 6500 rpm for 15 minutes
and stored at _20°C before Testosterone RIA
analysis (Gamma-B Testosterone Kit, IDS Ltd.).
Sperm concentrations were determined on
the last day of treatment (day 20). The rats were
killed and the vas deferens fluid was taken im-
mediately using a fIne needle syringe, which was
inserted into the vas deferens. A 10(1 aliquot of
vas deferens fluid was aspirated into the syringe
and then diluted to 2 ml in 0.95% saline solu-
tion and examined under light microscope. The
sperm concentration was determined using a
haemocytometer (Hafez 1987).
RESULTS AND DISCUSSION
Hypoglycaemic Study
The basal plasma glucose levels in the experi-
mental animals (230-300 mg%) were higher
compared to normal animals which have basal
levels in the range of 80 mg% to 100 mg%
(Noor and Ashcroft 1989 and Abdel-Barry et al.
1997). The high basal values confmned the
diabetic condition in the experimental animals.
Furthermore, there is no signilicant difference
in the readings at -10 minutes and 0 minute for
all treatment groups (Figure 1). This shows that
the diabetic condition in the animals was stable.
After the rats were given a glucose load of 1.5g/
kg body weight at time 0 minute, the plasma
glucose level of the rat group treated with saline
reached a peak at 30 minutes (388.38 mg%)
and very gradually became lower until it reached
the basal diabetic level after 120 minutes (Fig-
ure 1). Although Alloxan is believed to specili-
cally destroy the f3-eells (Chattopadhyay et al.
1997) there might be a chance of recovery from
the drug and the surviving f3-eells could still
produce insulin (Chattopadhyay et al. 1997) .
This explains the gradual lowering of the blood
glucose level from the peak to the basal diabetic
level. In the glibenclamide-administered group,
the peak blood glucose level was signilicantly
lower (ANOVA, p < 0.05, n = 5) (349.56 mg%)
compared to the saline control (388.38 mg%).
This shows that the drug (glibenclamide) was
effective in slowing the rate of increase in blood
glucose level after a glucose load. The decrease
in the blood glucose level might be due to the
possibility of stimulation of the ( cells to release
insulin (Ligtenberg et al. 1997).
Since the treatment of saline and
glibenclamide showed the ability of the blood
glucose level to reach basal diabetic level, the
results could indicate that the rats are from the
Type II diabetes mellitus (Non-Insulin Depend-
ent Diabetes Mellitus) categorised by insulin
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Fig. 1. Blood glucose concentration (mg%) at different time intervals (min) in diabetic rats
TABLE 2
Area under graph indicating blood glucose
concentration for each treatment
ote: Groups labeled with different letters are
significantly different compared to saline
control, P<0.05
deficiency or insulin resistance (Ferrannini 1998).
Invariably, the time taken for the high blood
glucose level in saline and glibenclamide groups
to reach basal diabetic level is longer (120 and
180 minutes respectively) compared to normal
rats where the blood glucose returned to basal
within 90 minutes to 120 minutes (Trejo-
Gonzilez et al. 1996 and Peungvicha et al. 1998)
The area under the graphs has been used to
indicate the amount of blood glucose level due
to the glucose load and also to see the effect of
the extracts (Leatherdale et al. 1981). The area
from the time of glucose load (0 minute) until
the end of the experiment (180 minutes) was
calculated for each treatment (Table 2). The
area under the glibenclamide graph (7.4358 x
Treatment
Glibenclamide
Saline
100 mg/kg
200 mg/kg
400 mg/kg
600 mg/kg
Area under graph
(x 103 mg%rninute)
7.4358 a
16.7434 b
25.9535 c
30.4419 c
29.4215 c
13.5818 d
103 mg%minute) is significantly lower than the
rest (ANOVA, p < 0.05, n = 5) (Figure 1). This
could be due to the increase in insulin release
and/or increase in glucose uptake by the pe-
ripheral cells stimulated by glibendamide
(Grodsky et al. 1963).
The extract of 600 mg/kg dose has an area
of 13.5818 x 103 mg%minute, which is signifi-
cantly less than that of the saline control (16.7434
x 103 mg%minute) but greater compared to
glibenclamide control graph (Figure 1). The
results showed that the extract might contain
some unidentified substances that can lower the
blood glucose level. However, three other lower
doses of the extracts (100 mg/kg, 200 mg/kg
and 400 mg/kg) did not show any hypoglycae-
mic properties or dose dependent effect as sta-
tistical data analysis (ANOVA, p < 0.05, n = 5)
did not show any significant increase in blood
glucose level compared to saline at all time
intervals.
Male Fertility Study
Mter 20 days of treatment, the extract doses of
60, 100 and 200 mg/kg body weight significantly
increased the sperm concentrations (Table 3)
by an average of 18% as compared to the con-
trol group. The 30 mg/kg group failed to show
any significant increase in sperm concentration
compared to the control. There were also no
significant differences in sperm concentrations
between the 60, 100 and 200 mg groups. The
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TABLE 3
Sperm concentrations of treatment groups after 20
days of treatment
Note: Groups labeled with different letters are
significantly different, P<0.05.
Data presented as mean ± s.d., n=4.
testosterone levels (Table 4) show a trend in-
crease for the 60 and 200 mg/kg groups for days
8 and 14 but it is not statistically significant due
to high standard error and a limited sample.
The sperm characteristics on all treatment groups
did not show any signs of abnormality.
The results failed to show concrete evidence
to suggest testosterone's direct role in increas-
ing sperm concentration. Other factors may have
contributed to the extract's spermatogenic ac-
tion. One possible explanation is that the seed
extract has anti-estrogenic properties. No stud-
ies has yet been done on P. major's anti estrogenic
properties but other plants have been known to
possess this property (Kanela 1974). Anti
estrogens act on the pituitary gland to stimulate
the production of FSH (Teoh 1987). FSH in-
creases the availability of germ cells at certain
steps of development during spermatogenesis
for entry into androgen dependant stages which
included stage 19 where spermatids are released
(Sharpe 1994). This coupled with the trend
increase in testosterone levels may have helped
to significantly increase the sperm concentra-
tions.
Treatment
Control
30 mg/kg
60 mg/kg
100 mg/kg
200 mg/kg
Sperm concentrations
(x 107 cells per ml)
123 ± 6.60 a
127 ± 6.16 a
144 ± 10.05 b
146 ± 7.04 b
144 ± 11.23 b
CONCLUSION
Results from the hypoglycaemic studies showed
that only the 600mg/kg P. major water extract
demonstrated hypoglycaemic effect on blood
glucose level in diabetic rats. The effect is, how-
ever, less pronounced compared to the estab-
lished hypoglycaemic agent, glibenclamide. The
use of the plant as a drug in treatment of
diabetes will depend on the proper processing
and dosages of the extracts in order to obtain
the desired hypoglycaemic effect. In the male
fertility study, the doses of 60, 100 and 200 mg/
kg were able to significantly increase sperm con-
centrations. There was also a trend in increased
testosterone levels from day 8 to 14 in the 60
and 200 mg/kg groups but it was insignificant
and suggested other factors, possibly
antiestrogens in the seed extract contributing to
the spermatogenic effect. All together, the stud-
ies suggest that aqueous extract from P. major
could contain chemicals for treating diabetes
mellitus and male fertility problems. Further
studies should be carried out to verify its hy-
poglycaemic and male antifertility effects.
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